HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A multicentre randomised trial comparing octreotide and injection sclerotherapy in the management and outcome of acute variceal haemorrhage.

AbstractBACKGROUND:
Few studies have compared vasoactive drugs with endoscopic sclerotherapy in the control of acute variceal haemorrhage. Octreotide is widely used for this purpose, but its value remains undetermined.
AIMS:
To compare octreotide with endoscopic sclerotherapy for acute variceal haemorrhage.
PATIENTS:
Consecutive patients with acute variceal haemorrhage.
METHODS:
Patients were randomised at endoscopy to receive either a 48 hour intravenous infusion of 50 pg/h octreotide (n = 73), or emergency sclerotherapy (n = 77).
RESULTS:
Overall control of bleeding and mortality was not significantly different between octreotide (85%, 62 patients) and sclerotherapy (82%, 63 patients) over the 48 hour trial period (relative risk of rebleeding 0.83; 95% confidence interval (CI) 0.38 to 1.82), irrespective of Child's grading or active bleeding at endoscopy. One major complication was observed in the sclerotherapy group (aspiration) and two in the octreotide group (pulmonary oedema, severe paralytic ileus). During 60 days of follow up there was an overall trend towards an increased mortality in the octreotide group which was not statistically significant (relative risk of dying at 60 days 1.91, 95% CI 0.97 to 3.78, p = 0.06).
CONCLUSIONS:
The results of this study indicate that intravenous octreotide is as effective as injection sclerotherapy in the control of acute variceal bleeding, but further controlled trials are necessary to evaluate the safety of this treatment.
AuthorsS A Jenkins, R Shields, M Davies, E Elias, A J Turnbull, M F Bassendine, O F James, J P Iredale, S K Vyas, M J Arthur, A N Kingsnorth, R Sutton
JournalGut (Gut) Vol. 41 Issue 4 Pg. 526-33 (Oct 1997) ISSN: 0017-5749 [Print] England
PMID9391254 (Publication Type: Clinical Trial, Comparative Study, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
Chemical References
  • Hormones
  • Octreotide
Topics
  • Acute Disease
  • Adult
  • Aged
  • Aged, 80 and over
  • Esophageal and Gastric Varices (drug therapy, mortality, therapy)
  • Female
  • Gastrointestinal Hemorrhage (drug therapy, mortality, therapy)
  • Hormones (therapeutic use)
  • Humans
  • Male
  • Middle Aged
  • Octreotide (therapeutic use)
  • Risk Factors
  • Sclerotherapy

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: